Screening for prostate cancer with prostate-specific antigen: beware the biases
- 23 October 2001
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 315 (1-2) , 71-97
- https://doi.org/10.1016/s0009-8981(01)00717-3
Abstract
No abstract availableKeywords
This publication has 142 references indexed in Scilit:
- RETRACTED: Prostate cancer screening in the Tyrol, Austria: experience and resultsEuropean Journal Of Cancer, 2000
- COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCERJournal of Urology, 2000
- Rationale for randomised trials of prostate cancer screeningEuropean Journal Of Cancer, 1999
- Comparison of pathologic characteristics of T1c and non-Tic cancers detected in a population-based screening study, the European randomized study of screening for prostate cancerWorld Journal of Urology, 1997
- Controversies in prostate cancer screening. Analogies to the early lung cancer screening debatePublished by American Medical Association (AMA) ,1996
- Longitudinal screening for prostate cancer with prostate-specific antigenPublished by American Medical Association (AMA) ,1996
- The impact of informed consent on patient interest in prostate-specific antigen screeningArchives of internal medicine (1960), 1996
- Screening for prostate cancer—Necessity or nonsense?European Journal Of Cancer, 1993
- The relationship of prostate‐specific antigen to digital rectal examination and transrectal ultrasonography: Findings of the American cancer society national prostate cancer detection projectCancer, 1992
- Progress and problems in screening for carcinoma of the prostateWorld Journal of Surgery, 1989